Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
Based on observations of 66 cases, in which tissues were specially processed to optimize the simultaneous preservation of cell membrane antigens and morphology, we provide evidence in favor of a relationship between follicular dendritic reticulum cells (FDRC) and Reed-Sternberg (RS) cells of Hodgkin's disease (HD) other than the lymphocyte predominance subtype. RS cells were intimately related to the FDRC network (75% of cases), and the expression of CD21 antigen was frequent (41% of cases). Exclusive expression of CD21 antigen was found in 11 cases of HD, while the expression of other B-cell-associated markers (CD19, CD20, CD22) was both variable and inconsistent. The expression of T-cell antigens (CD3, CD4, CD8) was rare. Null phenotype of RS cells was observed in 27 of 66 cases (41%). Epstein-Barr virus (EBV) nucleic acids were found in 34 of 66 (51.5%) cases. Double labeling techniques showed the presence of EBV-positive RS cells within the FDRC network. A non-B-cell origin of RS cells was supported by the differential expression of EBV latent antigens in HD (latent membrane protein+, EB nuclear antigen 2-), which is unusual in EBV-driven lymphoblastoid cell lines and EBV-positive B-cell lymphomas. FDRC and RS cells are known to share morphological traits (binucleated cells), and both cell types possess Fc receptor for IgG. The hypothesis is further backed by the findings of CD15 antigen expression by occasional RS-like dysplastic FDRC in Castleman's disease (five cases), which is characterized by hyperplasia of FDRC. Whether FDRC might be the only cells involved in the conversion to RS cells by the loss or gain of antigens remains to be determined.
Delsol
G
G
Laboratoire d'Anatomie Pathologique, CHU Purpan, Toulouse, France.
Meggetto
F
F
Brousset
P
P
Cohen-Knafo
E
E
al Saati
T
T
Rochaix
P
P
Gorguet
B
B
Rubin
B
B
Voigt
J J
JJ
Chittal
S
S
D000906:Antibodies / Q000032:analysis / Q000276:immunology; D015703:Antigens, CD / Q000032:analysis; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte / Q000032:analysis / Q000276:immunology; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis / Q000276:immunology; D000956:Antigens, Viral / Q000032:analysis; D005871:Castleman Disease / Q000276:immunology / Q000473:pathology; D002450:Cell Communication / Q000502:physiology; D004279:DNA, Viral / Q000235:genetics; D003713:Dendritic Cells / Q000276:immunology / Q000473:pathology* / Q000502:physiology; D015333:Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; D004854:Herpesvirus 4, Human / Q000276:immunology / Q000302:isolation & purification / Q000502:physiology; D006689:Hodgkin Disease / Q000209:etiology / Q000276:immunology* / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D010641:Phenotype; D017464:Receptors, Complement 3d / Q000032:analysis*; D017455:Receptors, IgE / Q000032:analysis; D016539:Reed-Sternberg Cells / Q000276:immunology / Q000473:pathology* / Q000502:physiology; D014763:Viral Matrix Proteins / Q000032:analysis
D000906:Antibodies; D015703:Antigens, CD; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte; D000945:Antigens, Differentiation, T-Lymphocyte; D000956:Antigens, Viral; D004279:DNA, Viral; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D017464:Receptors, Complement 3d; D017455:Receptors, IgE; D014763:Viral Matrix Proteins